article thumbnail

COVID-19 stuff

Molecular Design

However, I do realize that many people only follow the blog for the April Fools posts so I’ll link them here for easy reference [ 2013 | 2015 | 2016 | 2017 | 2018 | 2019 ]. A crystallographic fragment screen has been run against SARS-CoV-2 and a number of electrophilic fragments were screened using mass spectroscopy.

article thumbnail

Sygnature Discovery acquires Peak Proteins

Sygnature Discovery

In January 2016 Sygnature’s shareholders took a significant stake in the business and since then, Steve Young, VP of Business Development and Stuart Onions, SVP of Alliance Management at Sygnature have been board members of Peak Proteins.